Abstracts Archive - Page 182 of 1683 - ATC Abstracts

2022 American Transplant Congress
Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients
R. Alameer, M. Nguyen, P. Samanta
Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Invasive fungal infection (IFI) complicating Coronavirus disease of 2019 (COVID-19) has been increasingly recognized. IFI is a common opportunistic infection in solid organ transplant…
2022 American Transplant Congress
Impact of Kidney Allocation Change on Low Volume Kidney Transplant Centers
S. Nagaraju¹, S. Vaishnav¹, S. A. Deslich², S. Hanna¹, A. Jones³, J. B. Africa¹
¹Renal Transplant, Charleston Area Medical Center, Charleston, WV, ²Research Associate Senior, Health Services & Outcomes Rsc, Charleston Area Medical Center, Charleston, WV, ³Charleston Area Medical Center, Charleston, WV
*Purpose: Effective March 15, 2021, the OPTN launched a new policy for matching kidney and pancreas transplant candidates with organs from deceased donors. The new…
2022 American Transplant Congress
The Impact of Early Graft Infiltrating TCF-1^LowPD-1^HighCD8⁺ T Cells in Delayed Fc Nonbinding Anti-CD3 Antibody Protocol in the Sensitized Mouse Model
T. Ota¹, R. Goto¹, T. Harada¹, Y. Ganchiku¹, M. Zaitsu¹, A. Forgioni¹, N. Kawamura², M. Watanabe², M. Fukai¹, T. Shimamura³, A. Taketomi¹
¹Dept. of Gastroenterological Surgery I, Hokkaido University, Sapporo, Japan, ²Dept. of Transplant Surgery, Hokkaido University, Sapporo, Japan, ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Fc nonbinding anti(a)-CD3 antibody has a unique effect that delayed treatment protocol induces a transplant tolerance. Delayed protocol allows early graft infiltrating cells which…
2022 American Transplant Congress
National Survey of Solid Organ Transplant Pharmacist Training and Early Career Research Success
A. Lichvar¹, M. Chandran², M. Durst³, S. Fredrick⁴, D. Pierce⁵, H. Sweiss⁶, A. Szczepanik⁷, J. Melaragno⁸
¹UC San Diego Health, La Jolla, CA, ²Pharmacy, UNC Hospitals, Chapel Hill, NC, ³Aurora St. Luke's Medical Center, Waukesha, WI, ⁴University of Rochester Medical Center, Buffalo, NY, ⁵University of Illinois at Chicago, Chicago, IL, ⁶University Health - University Hospital, San Antonio, TX, ⁷University of Maryland, Baltimore, MD, ⁸University of Rochester, Rochester, NY
*Purpose: The purpose of this study is to assess the incidence of early career publications of solid organ transplant (SOT) clinical pharmacists and to describe…
2022 American Transplant Congress
Safety and Efficacy of a Probiotic Protocol to Reduce Perioperative Infection After Liver Transplantation
M. Jorgenson, Q. Yang, G. Leverson, C. Saddler, J. Smith, N. Safdar, D. Al-Adra
University of Wisconsin Health, Madison, WI
*Purpose: Evaluate efficacy and safety of a probiotic preparation to reduce perioperative infection in patients undergoing liver transplant surgery*Methods: Adult patients receiving liver transplantation from…
2022 American Transplant Congress
Frequency of Cervical Cancer Screening in Solid Organ Transplant Recipients
C. Papastamelos¹, K. Dokus², M. Laryea³
¹Internal Medicine, University of Rochester Medical Center, Rochester, NY, ²Transplant Division, University of Rochester Medical Center, Rochester, NY, ³Gastroenterology, University of Rochester Medical Center, Rochester, NY
*Purpose: Human papillomavirus-related anogenital malignancies disproportionately affect solid organ transplant recipients (SOTR) compared to the general population. Proposed cervical Pap testing intervals for SOTR differ…
2022 American Transplant Congress
Immunosuppressant Medications Use in Patients with Transplant Failure: A Canadian Multi-Centre Prospective Study
G. Knoll¹, M. Chassé², D. Fergusson³, A. A. House⁴, O. Johnston⁵, R. Mainra⁶, D. Baran⁷, D. Treleaven⁸, l. senecal⁹, L. Tibbles¹⁰, M. Hebert¹¹, M. Karpinski¹², T. Campbell¹³, T. Ramsay¹⁴, J. Kim¹⁵, I. Houde¹⁶, C. White¹⁷, J. Perl¹⁵, P. Karnabi¹⁸, J. Gill⁵
¹Nephrology, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ²University of Montreal, Montreal, QC, Canada, ³Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁴Nephrology, Western University, London, ON, Canada, ⁵Nephrology, University of British Columbia, Vancouver, BC, Canada, ⁶Nephrology, University of Saskatchewan, Saskatoon, SK, Canada, ⁷Nephrology, McGill University, Montreal, QC, Canada, ⁸Nephrology, McMaster University, Hamilton, ON, Canada, ⁹Nephrology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada, ¹⁰Nephrology, University of Calgary, Calgary, AB, Canada, ¹¹Nephrology, University of Montreal, Montreal, QC, Canada, ¹²Nephrology, University of Manitoba, Winnipeg, MB, Canada, ¹³University of Alberta, Alberta, AB, Canada, ¹⁴Ottawa Hospital Research Institute, Ottawa, ON, Canada, ¹⁵University of Toronto, Toronto, ON, Canada, ¹⁶Laval University, Que´bec, QC, Canada, ¹⁷Queen's University, Kingston, ON, Canada, ¹⁸Ottawa Health Research Institute, Ottawa, ON, Canada
*Purpose: This prospective study determined the association of immunosuppressant medication use with the outcomes of death, hospitalized infection, rejection of the failed allograft, and panel…
2022 American Transplant Congress
Non-Invasive Assessment of Hepatic Ischemia-Reperfusion Injury Using Dynamic Contrast Enhanced-MRI and T2 Mapping
O. C. Rodriguez¹, J. R. Liggett², J. Kang², K. Loh², Y. Lee¹, N. Sang¹, B. He¹, Y. Cui², K. Oza², D. Kwon³, B. Kallakury³, T. Fishbein², W. Cui², K. Khan², C. Albanese¹, A. Kroemer²
¹Lombardi Comprehensive Cancer Center and the Center for Translational Imaging, Georgetown University Medical Center, Washington, DC, ²MedStar Georgetown Transplant Institute, Washington, DC, ³Pathology, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Hepatic ischemia-reperfusion injury (IRI) is a consequence of liver transplantation and hepatectomy that varies in severity and clinical significance. The diagnosis is made based…
2022 American Transplant Congress
The Effect of Adoption of Acuity Circles on Hepatocellular Carcinoma Transplantation Rates at a Single High Acuity Center
D. W. Victor III, J. Corkrean, S. Kodali
Sherrie and Allan Conover Center for Liver disease and Transplantation, Houston Methodist Hospital, Houston, TX
*Purpose: Transplantation for selected patient with HCC has been prioritized with a MELD exception since 2002. Further changes have decreased the maximum exception for HCC.…
2022 American Transplant Congress
Understanding Transplant Awareness in Pre-Kidney Transplant Recipients – Role of Surgeon Visit
G. Defelice, H. Harrington, M. Ratcliff, D. Moravec, E. Wands, A. Sauviac, A. Paramesh, A. Vijay
Tulane University School of Medicine, New Orleans, LA
*Purpose: Education for pre-Kidney Transplant recipient candidates aims to improve their knowledge and understanding about the transplant process, outcomes and potential complications and facilitate adjustment…